Kocostar Face Therapy Acne Treatment Cre Am to Pat Ch

Description

The provided information does not specify the chemical name, physical characteristics, or inactive ingredients of the drug. Therefore, a detailed description cannot be formulated based on the available data. Further information is required to create a comprehensive description.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne blemishes and facilitates the healing of the skin. Additionally, it helps prevent the formation of new acne blemishes.

There are no teratogenic or nonteratogenic effects mentioned associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product must be shaken well before use. A thin layer should be applied to the entire affected area using a sterile cotton swab. After application, it is essential to allow the product to dry completely and to leave it in place for a duration of 8 hours to facilitate healing.

To remove the product, the area should be wetted with warm water, and the product can be gently rolled off using the fingertips.

Initial treatment should consist of one application daily. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily. In cases where excessive dryness or peeling occurs, it is advisable to reduce the application frequency to once a day or every other day.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

For external use only. This product is contraindicated for application on broken skin or large areas of the skin. Caution is advised when using this product concurrently with other topical acne medications, as the likelihood of skin irritation and dryness may increase. In the event of irritation, it is recommended to discontinue use of all topical acne medications and utilize only one at a time.

Healthcare professionals should instruct patients to cease use and consult a physician if irritation becomes severe. Additionally, it is imperative to avoid contact with the eyes; should contact occur, the affected area must be flushed thoroughly with water. In cases of ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this medication should be aware that it is intended for external use only and should not be applied to broken skin or large areas of the skin. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time.

Severe irritation may necessitate discontinuation of the product, and patients are advised to consult a healthcare professional if such symptoms arise. Additionally, care should be taken to avoid contact with the eyes; should contact occur, it is important to flush the eyes thoroughly with water.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the products should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended during the use of this product in conjunction with other topical treatments.

Packaging & NDC

Below are the non-prescription pack sizes of Kocostar Face Therapy Acne Treatment Cre Am to Pat Ch (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for safety in pregnancy. The use of salicylic acid during pregnancy is generally contraindicated due to potential risks to the fetus, including possible teratogenic effects. Pregnant women should consult a healthcare provider before using this product. It is advised to avoid the use of this product during pregnancy unless directed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact the Poison Control Center. This information is vital for ensuring patient safety and prompt intervention in case of an emergency.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from heat sources and direct sunlight to maintain its integrity.

To preserve the quality of the product, lids must be kept tightly closed when not in use. Additionally, it is important to avoid dipping used cotton swabs into the essence to prevent contamination and ensure safe handling.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Kocostar Face Therapy Acne Treatment Cre Am to Pat Ch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)